Sheaff Brock Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,097
Closed -$209K 549
2018
Q3
$209K Buy
+1,097
New +$202K 0.02% 433
2018
Q1
Sell
-2,440
Closed -$399K 591
2017
Q4
$399K Sell
2,440
-2,006
-45% -$360K 0.05% 296
2017
Q3
$911K Buy
4,446
+223
+5% +$51.9K 0.12% 164
2017
Q2
$1.03M Buy
4,223
+130
+3% +$30.5K 0.14% 145
2017
Q1
$978K Buy
4,093
+35
+0.9% +$8.15K 0.13% 148
2016
Q4
$852K Sell
4,058
-2,225
-35% -$461K 0.11% 196
2016
Q3
$1.45M Buy
6,283
+164
+3% +$40.1K 0.19% 111
2016
Q2
$1.41M Buy
6,119
+1,521
+33% +$351K 0.18% 117
2016
Q1
$1.23M Sell
4,598
-468
-9% -$134K 0.15% 143
2015
Q4
$1.58M Buy
+5,066
New +$1.51M 0.18% 135

Other funds holding AGN

Sheaff Brock Investment Advisors's AGN Position: Q4 2018 in Review

Sheaff Brock Investment Advisors sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,097 shares — an estimated $209K sold.

Sheaff Brock Investment Advisors first reported a position in AGN in Q4 2015 and held it in 10 quarters. The position peaked at $1.58M in Q4 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Sheaff Brock Investment Advisors reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 1,097 Allergan plc shares in Q4 2018, an estimated $209K.
  • Sheaff Brock Investment Advisors first reported a position in Allergan plc in Q4 2015 and held it in 10 quarters.
  • Sheaff Brock Investment Advisors's Allergan plc position peaked at $1.58M in Q4 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Sheaff Brock Investment Advisors's 13F filing for Q4 2018, filed 28 Jan 2019.